PRELUDE THERAPEUTICS INC

Ticker: PRLD CUSIP: 74065P101 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 28,613 Value ($000) $22 Avg Close $0.93 Range $0.63 - $1.43
Q4 2024
Shares 28,613 Value ($000) $36 Avg Close $1.33 Range $0.80 - $2.10
Q3 2024
Shares 28,613 Value ($000) $59 Avg Close $4.63 Range $1.98 - $6.80
Q2 2024
Shares 36,276 Value ($000) $138 Avg Close $4.07 Range $3.32 - $5.83
Q1 2024
Shares 40,068 Value ($000) $190 Avg Close $3.89 Range $2.62 - $5.00
Q4 2023
Shares 50,600 Value ($000) $216 Avg Close $3.04 Range $1.66 - $4.65
Q3 2023
Shares 32,882 Value ($000) $102 Avg Close $3.75 Range $2.65 - $5.01
Q2 2023
Shares 30,816 Value ($000) $139 Avg Close $5.98 Range $4.25 - $8.56
Q4 2022
Shares 28,879 Value ($000) $174 Avg Close $6.41 Range $4.49 - $8.66
Q3 2022
Shares 29,179 Value ($000) $193 Avg Close $6.74 Range $4.77 - $8.90
Q2 2022
Shares 29,189 Value ($000) $153 Avg Close $5.09 Range $3.87 - $7.96
Q1 2022
Shares 59,820 Value ($000) $412 Avg Close $9.15 Range $6.76 - $13.40
Q4 2021
Shares 57,676 Value ($000) $718 Avg Close $16.27 Range $10.96 - $32.77
Q3 2021
Shares 34,312 Value ($000) $1,072 Avg Close $32.38 Range $24.72 - $43.55
Q2 2021
Shares 30,254 Value ($000) $866 Avg Close $35.61 Range $28.26 - $45.42
Q1 2021
Shares 31,036 Value ($000) $1,345 Avg Close $66.34 Range $37.01 - $95.38
Q4 2020
Shares 30,973 Value ($000) $2,216 Avg Close $49.73 Range $27.53 - $89.06